According to InnovAge's latest financial reports the company's current EPS (TTM) is -$0.31. In 2022 the company made an earnings per share (EPS) of -$0.28 a decrease over its 2021 EPS that were of $0.03000.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.31 | 10.71% |
2022 | -$0.28 | -1033.33% |
2021 | $0.03000 | -120.79% |
2020 | -$0.14 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Merck MRK | $1.23 | -496.77% | ๐บ๐ธ USA |
![]() Cocrystal Pharma
COCP | -$2.29 | 638.71% | ๐บ๐ธ USA |
![]() AcelRx Pharmaceuticals
ACRX | -$3.09 | 896.77% | ๐บ๐ธ USA |
![]() Horizon Therapeutics
HZNP | $1.92 | -719.35% | ๐ฎ๐ช Ireland |